Chief Financial Officer

Chien-Chien “CC” Jacques has a Master’s Degree in Accounting and Financial Management from the University of Maryland and is an actively licensed CPA. Most recently, she was the Chief Financial Officer at Nava Health creating the company’s first, formal accounting department and achieving SEC-declared effectiveness in its IPO efforts. Prior to that, she was the Vice President of Finance & Accounting at Vigene Biosciences, a gene therapy CDMO. CC spearheaded Vigene’s formal accounting practices from the ground up as well and ultimately oversaw the financial aspects of its acquisition by Charles River Labs.

CC has almost two decades of finance and accounting leadership experience with more than half of that time in the biotech/alternative therapies space. She has a personal passion for making advanced medicine accessible and affordable for everyone.